Research map: Invasiveness, SOX2 Expression, and Resection Outcomes in TF-Defined PitNETs After Extra-Pseudocapsular Resection

Back to the article

Papers in this map

  1. Overview of the 2022 WHO Classification of Pituitary Tumors · Sylvia L. Asa · 2022 · 658 citations · Cited by this paper
  2. Peptide Loading Complex in Cancer: From Peptide Translocation, Editing, and Loading into MHC-I to a Potential Therapeutic Target · 2026 · Related
  3. Pangenomic Classification of Pituitary Neuroendocrine Tumors · Mario Néou · 2019 · 341 citations · Cited by this paper
  4. METTL3–m6A–LOXL2 Axis Post-Transcriptionally Fine-Tunes Macrophage Migration and Invasion · 2026 · Related
  5. Molecular Network Basis of Invasive Pituitary Adenoma: A Review · Qi Yang · 2019 · 82 citations · Cited by this paper
  6. Overcoming the Viscosity-Strength Trade-Off in 3D-Printable Dental Resins by Hydrogen Bond Engineering · 2026 · Related
  7. The optimal surgical techniques for pituitary tumors · Michael Buchfelder · 2019 · 71 citations · Cited by this paper
  8. Predictive Value of Admission Renal Injury-Related Indicators for Fatal Outcomes in Patients with Severe Fever with Thrombocytopenia Syndrome · 2026 · Related
  9. Development and clinical validation of a grading system for pituitary adenoma consistency · Martin J. Rutkowski · 2020 · 67 citations · Cited by this paper
  10. Integrated DNA Repair Capacity and NER Gene Expression for Improving Risk Prediction in Head and Neck Squamous Cell Carcinoma · 2026 · Related
  11. Pituitary neuroendocrine tumors with PIT1/SF1 co-expression show distinct clinicopathological and molecular features · Matthias Dottermusch · 2024 · 48 citations · Cited by this paper
  12. Pain Medicine Specialist: Championing High-Quality Development for Neuromodulation Technology · 2026 · Related
  13. Clinical Concerns about Recurrence of Non-Functioning Pituitary Adenoma · Min Ho Lee · 2016 · 35 citations · Cited by this paper
  14. Trehalose: A Promising Therapeutic Agent for Diverse Pathological Conditions · 2026 · Related
  15. Experimental Evidence and Clinical Implications of Pituitary Adenoma Stem Cells · Roberto Würth · 2020 · 31 citations · Cited by this paper
  16. Strategies for Evading Cellular Immunity Against Recombinant AAV Vectors in Gene Therapy · 2026 · Related
  17. Classifying Pituitary Adenoma Invasiveness Based on Radiological, Surgical and Histological Features: A Retrospective Assessment of 903 Cases · Liang Lü · 2022 · 30 citations · Cited by this paper
  18. Advances and Clinical Applications of Thrombopoietic Agents · 2026 · Related
  19. Clinical and Pathological Features of Pit1/SF1 Multilineage Pituitary Neuroendocrine Tumor · Xingchao Wang · 2024 · 13 citations · Cited by this paper
  20. Bone Morphogenetic Proteins in Obesity Management: Therapeutic Potential and Challenges Beyond the Skeleton · 2026 · Related
  21. Association between pituitary adenoma consistency, resection techniques, and patient outcomes: a single-institution experience · Gage A. Guerra · 2025 · 13 citations · Cited by this paper
  22. Hormone Markers in Pituitary Adenomas: Changes Within Last Decade Resulting from Improved Method · Wolfgang Saeger · 2003 · 12 citations · Cited by this paper
  23. Clinicopathological Characteristics of Plurihormonal Pituitary Adenoma · Ruoyu Shi · 2022 · 12 citations · Cited by this paper
  24. Treatment Strategies and Long-Term Outcomes in Silent Corticotroph Adenomas: A Single-Center Retrospective Study of 367 Cases · Wenqiang He · 2024 · 8 citations · Cited by this paper
  25. Surgical Technique and Efficacy Analysis of Extra-pseudocapsular Transnasal Transsphenoidal Surgery for Pituitary Microprolactinoma · Xueyan Wan · 2022 · 7 citations · Cited by this paper
  26. Extracapsular Resection of Pituitary Adenomas: A Systematic Review · Kenny Seng · 2023 · 7 citations · Cited by this paper
  27. A clinicopathological study of non-functioning pituitary neuroendocrine tumours using the World Health Organization 2022 classification · Chariene Shao Lin Woo · 2024 · 6 citations · Cited by this paper
  28. Pituitary tumours without distinct lineage differentiation express stem cell marker SOX2 · Nèle F Lenders · 2024 · 5 citations · Cited by this paper
  29. The Expression of Stem Cell Markers (CD133, NESTIN, OCT4, SOX2) in Invasive Pituitary Adenomas · Recep Başaran · 2020 · 4 citations · Cited by this paper

Source: OpenAlex (CC0)